*

RUPI

DHILLON

** ************ *****, ********, **

937-***-****

adkfof@r.postjobfree.com

OBJECTIVE

Seeking a position in an innovative department looking to add a compassionate and driven physician assistant. Highly motivated, hardworking team player, graduate of an accredited Physician Assistant Program. Strong clinical background and excellent patient care experience.

EDUCATION

Physician Assistant Le Moyne, Syracuse, New York DATES FROM AUG 2017– AUG 2020

MBBS, Bachelor’s in medicine & Bachelor’s in surgery Dayanand Medical College DATES FROM AUG 1998– AUG 2005 & Hospital, Ludhiana India

Bachelor of Science (Honors) University of Akron, Ohio DATES FROM AUG 1994– JUNE 1998

EXPERIENCE

Physician Assistant PA-C Rome Memorial Hospital, Rome New York DATES FROM DEC. 2020- PRESENT

• Provide medical treatment to Emergency Department patients

• Examines, diagnoses, and treats patients of all ages with acute illnesses and injuries or exacerbations of chronic disease

• Knowledge of pharmaceuticals, their indications, interactions, contradictions and effects.

• Orders evidence-based testing, prescribes medications and refers to outside specialist as required

• Ability to use specialized medical equipment such as electrocardiograms

• Educate patients on overall wellness and health maintenance

• Maintain a safe and clean work environment

• Maintains patient charts accurately and comprehensively

• Documents patient information in Electronic Medical Record (EMR)

Adjunct Professor Cuyahoga Community College, Cleveland, Ohio DATES FROM JAN. 2016– TO AUG 2017

• Lectured and taught the material presented in the course syllabus and outline in a professional and engaging manner.

• Developed a course outlines, curriculum and instructional materials to improve the processes and courses offered to students as they seek their chosen degree 2

Clinical Research Specialist University Hospitals Case Medical Center, DATES FROM OCT. 2010– TO JAN, 2012 Cleveland, Ohio

• Trained and educated PI’s, Co-I’s, fellows, residents, and students on Protocols and Consenting Process and the importance and the “how to.”

• Oversaw Consenting Processes documentation for P.I.’s, Co-I, PhD’s, fellows, residents and students.

Clinical Research Coordinator Hometown Urgent Care & Occupational Health DATES FROM OCT. 2010– TO JAN, 2012 Dayton, Ohio

• Reviewed medical history, monitored medications and lab values to ensure patients continued to meet criteria and determine dose modification if necessary.

• Performed ECG’s, Blood Pressure, Blood Glucose Levels, Pregnancy Tests, Drug Screens, etc. per Subject enrollee

SKILLS

• Ability to respond to emergencies and

unpredictable situations exercising

good judgement

• Strong attention to detail, evaluation

and diagnosis

• Ability to learn, perform and assist

with variety of procedures

• Team Player and people person

• Documentation and Charting

• Excellent interpersonal skills, basic

computer skills, strong verbal and

written communication skills

• Applying evidence-based medicine in

practice

OCCUPATIONAL TRAINING

• CITI Good Clinical Practice

• CPR Certification

• ACSL Certification

• BLS Certification

• PALS Certification

• HIPPA Certification

• NYS Infection Control Training

• Data Management Series for Research

• Training in Identification of Reporting

of Child Abuse and Maltreatment

• MAT Certificate

• Management of Pain

• Approach to Acutely Ill Patients

• Coronavirus Education

Certificate

• Ethical and Psychosocial Issues

in Management of COVID-19

• Compliance Certificates

3

AWARDS

• Distinction in Third Professional in

Dayanand Medical College & Hospital

• Member of Phi Sigma Alpha Honorary

Society

• Golden Key National Honors

PUBLICATIONS

• Outstanding Academic

Achievement

• Diversity Award & Most

Outstanding Student leader

• Presidential Academic Award

• What Barriers Prevent Compliance in at Risk Populations and Patients. A Systematic Review. Lemoyne College. May 10, 2019.

• Double Blind, Comparative Study of Micafungin versus Caspofungin as Antifungal Treatment in Patients with Invasive Candidiasis or Candidemia. A Phase 3. Dayanand Medical College & Hospital. NCT00105144

COMMUNITY SERVICE

• Rescue Mission of Syracuse

• Amaus Health Service at The Cathedral of Immaculate Conception, Syracuse RESEARCH STUDIES INVOLVED IN

• Gulani, Vikas, MD, PhD. Assessment of MRI Technology - Retrospective Chart Review quantitative MRI, chart review

• Tarr, Robert W. MicroVention Low Profile Visualized Intraluminal Support or LVIS Jr. Humanitarian use device. MicroVention LVIS HDE

• Tarr, Robert W .Humanitarian Use Device: The Wingspan Stent System with Gateway PTA Balloon Catheter

• Sunshine, Jeffrey. Emergency Use of ENTERPRISE VASCULAR RECONSTRUCTION DEVICE AND DELIVERY SYSTEM

• Sunshine, Jeffrey .CODMAN ENTERPRISE® Vascular Reconstruction Device and Delivery System approved under Humanitarian Device Exemption (HDE) H060001

• Paspulati, Raj Mohan, MD. Retrospective evaluation of the clinical characteristic associated with patient claustrophobia during MRI examination.

• Gilkeson, Robert C. Evaluation of Dual-Energy Digital Radiography for the Detection of Cardiothoracic Diseases Evaluation of Dual-Energy Digital Radiography

• Gulani, Vikas, MD, PhD. Assessment of advanced Imaging techniques in the evaluation and management of prostate cancer and correlation of imaging findings with clinical findings and patient outcomes Advanced Imaging and Prostate Cancer

• Gulani, Vikas, MD, PhD. Assessment of Magnetic Resonance Fingerprinting (MRF) for predicting 4

tumor response after neoadjuvant chemo radiation therapy in rectal cancer and colorectal cancer metastasis to liver

• Gulani, Vikas, MD, PhD. Copy of Assessment of MRI Technology - Retrospective Chart Review Quantitative MRI, chart review

• Gulani, Vikas, MD, PhD. Development of Magnetic Resonance Imaging Technology Development MRI Technology

• Gulani, Vikas, MD, PhD. Minimal Data Requirements for Accurate MRI Diagnosis of Liver Lesions Hepatic MRI Data Reduction

• Gulani, Vikas, MD, PhD Assessment of novel MRI quantification free breathing technique in evaluation of liver lesions MRI, liver, biopsy

• Gulani, Vikas, MD, PhD. Quantitative MR Angiography and Perfusion (MRAP) Imaging for Assessing Disease Status and Treatment in Peripheral Arterial Disease

• Abouassaly, Robert. Novel Screening MRI for the Detection of Prostate Cancer Screening, MRI, Pro

• Jones, Robert S, Ohio . NaF PETMRI evaluation for bone metastases in Breast Cancer bone, cancer and radiology

• Paspulati, Raj Mohan, MD. Retrospective study comparing prostate MRI for transitional zone carcinomas to surgical specimen histopathological findings.

• Landeras, Luis. Data Collection for Philips CAD Regulatory Clearance Philips CAD Validation

• Haaga, John. Immuno-histochemical Staining of Archived tissue biopsy samples Immuno- histochemical Staining of Archived tissue biopsy samples

• Robbin, Mark R. Non-Delay iMRA versus traditional iMRA and non-contrast MRI in evaluation of glenoid labrum Non-Delay iMRA

• Nakamoto, Dean A, MD. Percutaneous Cryoablation for the Palliation of Abdominal Pain Associated with Pancreatic Cancer Percutaneous Cryoablation

• Gilkeson, Robert C. Preliminary assessment of the added diagnostic value of post processed detector- based dual energy Computed Tomography (DECT) images using data acquired on the Spectral Detector Computed Tomography (SDCT) preliminary assessment detector dual-energy CT, image post- processing

• Rajiah, Prabhakar, MD. Comparison of the image quality between a single energy CT scanner and the conventional images from a Spectral scanner Conventional CT vs SDCT

• Avril, Norbert. MR Acquisition Optimization and Validation in Volunteers MRI (of PET/MRI) on normal volunteers

• Robbin, Mark R. Simulation-Based Interventional Education Curriculum Radiology, interventional, simulation

• Tarr, Robert W. Humanitarian Use Device: The Neuroform TM Microdelivery EZ Stent System Neuroform, Micro Delivery, stent

• Sunshine, Jeffrey. Radiology workflow efficiency

• Gilkeson, Robert C. Retrospective review of incidental lung nodules detected during coronary artery calcium scoring test with MDCT incidental, pulmonary, coronary

• Sunshine, Jeffrey. Anatomical Linking for Improved Reading Efficiency of Radiological Images Radiology, Reading, Image registration

• Gilkeson, Robert C. Computer Aided Detection of Lung Cancer with Dual Energy Digital Radiography CAD of Lung CA with Dual Energy

• Nakamoto, Dean A, MD. Image Guided sclerotherapy for treatment of vascular anomalies. sclerotherapy, vascular malformation, lymphatic malformation

• Robbin, Mark R. Long-Term Follow-Up of Osteoid Osteoma after treatment with radiofrequency ablation Osteoid Osteoma follow-up

• Robbin, Mark R. Comparison of diagnostic accuracy between using Bonopty Bone Biopsy Kits versus using Laurane Bone Biopsy Kits. Bone Biopsy Accuracy

• Robbin, Mark R .Copy of Non-Delay iMRA versus traditional iMRA and non-contrast MRI in evaluation of glenoid labrum; Non-Delay iMRA

• Phase I, A Randomized, Double Blind, Placebo Controlled, Ascending Dose Study to Evaluate the Safety and Efficacy of CEP-37247 Administered at Single Doses of 0.5, 1,3,6, or 12mg by the Transforaminal Epidural Route for the Treatment of Patients with Lumbosacral Radicular Pain Associated with Disk Herniation.

5

• Phase 3, A 12 Week, Randomized, Double Blind, Placebo Controlled Study of Asimadoline in Subjects with Diarrhea- Predominant Irritable Bowel Syndrome. (D-IBS)

• Phase 2, A Multicenter, Randomized, Double Blind, Placebo Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients with Primary Fibromyalgia.

• Phase 3, A Multicenter, Randomized Active Control Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities.

• Phase 3, A Randomized, Double Blind, Placebo Controlled, Multicenter Trial with an Enriched Study Design to Assess the Efficacy and Safety of Oxycodone/ Naloxone Controlled release Tablets (OXN) Compared to Placebo in Opioid experienced Subjects with Moderate to Severe Pain due to Chronic Low Back Pain who Required Around the Clock Opioid Therapy.

• Phase 3, A Randomized, Double Blind, Placebo Controlled, Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients with Diarrhea- Predominant Irritable Bowel Syndrome.

• Phase 3, Randomized, Double Blind, Parallel Group study to Evaluate the Efficacy and safety of once daily oral administration of BI 10773 25mg/ linagliptin 5mg and BI 10773 10mg/ linagliptin 5mg Fixed Dose Combination tablets compared with the individual Component for 52 weeks in treatment naïve and metformin treated patient with type 2 diabetes mellitus with insufficient glycemic control.

• Phase 3, A Randomized, Double Blind, Placebo Controlled, multidose, pivotal study to determine the efficacy and safety of SST 0225, a topical ibuprofen cream, in the treatment of pain associated with acute ankle sprain.

• A 14 Week Randomized Parallel Group Placebo-Controlled Double-Blind Multicenter Study Of Fesoterodine 8 Mg In Overactive Bladder Patients With Sub-Optimal Response To Tolterodine 4 Mg Extended Release (ER)

• A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D)

• Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation

• “Title of Project : A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma’

• MK-3475-051: A Phase I/II Study of MK-3475 (Pembrolizumab) in Children with advanced melanoma or a PD-L1 positive advanced, relapsed or refractory solid tumor or lymphoma

• Multicenter, randomized, double-blind, double-dummy, active-comparator, event-driven, superiority phase III study of secondary prevention of stroke and prevention of systemic embolism in patients with a recent Embolic Stroke of Undetermined Source (ESUS), comparing rivaroxaban 15 mg once daily with aspirin 100 mg (NAVIGATE ESUS)

6

Contact this candidate